Stock DNA
Pharmaceuticals & Biotechnology
VND Million (Micro Cap)
0
NA
0.00%
0.09
-3.57%
0.00
Revenue and Profits:
Net Sales:
7,234 Million
(Quarterly Results - Mar 2026)
Net Profit:
-8,247 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
-48.28%
0%
-48.28%
1 Year
-61.54%
0%
-61.54%
2 Years
-59.46%
0%
-59.46%
3 Years
-87.34%
0%
-87.34%
4 Years
-87.44%
0%
-87.44%
5 Years
-83.84%
0%
-83.84%
American Vietnamese Biotech, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.99%
EBIT Growth (5y)
-182.66%
EBIT to Interest (avg)
2.61
Debt to EBITDA (avg)
1.50
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.15
Tax Ratio
58.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.68%
ROE (avg)
4.40%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-5.24
EV to EBITDA
-55.57
EV to Capital Employed
0.09
EV to Sales
0.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.63%
ROE (Latest)
-3.57%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
7,233.90
39,522.10
-81.70%
Operating Profit (PBDIT) excl Other Income
1,300.90
2,063.60
-36.96%
Interest
1,902.90
4,983.00
-61.81%
Exceptional Items
0.00
197.10
-100.00%
Consolidate Net Profit
-8,247.10
-3,293.60
-150.40%
Operating Profit Margin (Excl OI)
-957.60%
52.20%
-100.98%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -81.70% vs 211.42% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -150.40% vs 69.68% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
154,066.60
310,354.60
-50.36%
Operating Profit (PBDIT) excl Other Income
5,327.00
19,689.90
-72.95%
Interest
18,655.30
19,650.50
-5.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-54,503.70
-13,065.20
-317.17%
Operating Profit Margin (Excl OI)
-179.00%
-13.90%
-16.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -50.36% vs 57.88% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -317.17% vs -221.74% in Dec 2024
About American Vietnamese Biotech, Inc. 
American Vietnamese Biotech, Inc.
Pharmaceuticals & Biotechnology
American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.
Company Coordinates 
Company Details
So 1251 QL 14, thi xa Dong Xoai , HO CHI MINH None : None
Registrar Details






